We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us

Download Mobile App




Endoscopic Ablation System Treats Paroxysmal Atrial Fibrillation

By HospiMedica International staff writers
Posted on 21 Apr 2016
Print article
Image: The HeartLight endoscopic ablation system (Photo courtesy of CardioFocus).
Image: The HeartLight endoscopic ablation system (Photo courtesy of CardioFocus).
Innovative catheter ablation technology allows clinicians to visually direct laser energy for achieving durable pulmonary vein isolation (PVI) in the treatment of atrial fibrillation (AF).

The HeartLight Endoscopic Ablation System is intended for the treatment of drug refractory recurrent symptomatic paroxysmal AF. The system is based on a near infrared (NIR) laser light and a deflectable sheath that provides efficient transseptal access for ablation of all four pulmonary veins. The sheath is first used to transport a catheter to the vicinity of the vein using fluoroscopy, whereupon the compliant balloon is inflated. Once tissue contact is achieved, an integral micro-endoscope is used to visualize the placement of the balloon relative to the ostium of the vein.

The physician then uses the endoscopic image acquired by direct visualization to determine placement of each arc of NIR laser light, in order to place overlapping arcs into the atrial wall around each vein. The endoscope also provides feedback on progress obtained in achieving vein isolation via a dynamic view of the developing lesions on the cardiac tissue. The scar tissue creates a conduction block with just several 20-30 second energy deliveries. The HeartLight system is a product of CardioFocus (Marlborough, MA, USA), and has been approved by the US Food and Drug Administration (FDA).

“Based on our experience in the CardioFocus pivotal study and the successful results from the European Union, I am confident that this new laser balloon catheter will offer our patients an outstanding treatment option for atrial fibrillation,” said Frank Cuoco, MD, of the Medical University of South Carolina (Charleston, SC, USA). “The flexibility of the compliant balloon, which is intuitive to use under direct visual guidance, is one of its primary appeals. I found the learning curve to be very short.”

PVI is a catheter ablation technique developed to prevent focal triggers in the pulmonary veins from initiating episodes of AF. Although the procedure initially involved focal ablation with a catheter directly in the pulmonary veins, applying ablation energy at their junction with the left atrium is more effective. The PVI procedure is most suitable for patients whose recurring symptomatic episodes of AF that have not been suppressed by anti-arrhythmic drugs, or who do not wish to take long- term anti-arrhythmic or anticoagulation medications.

Related Links:
CardioFocus


Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
Disposable Protective Suit For Medical Use
Disposable Protective Suit For Medical Use
Silver Member
Wireless Mobile ECG Recorder
NR-1207-3/NR-1207-E
New
LED Examination Light
LUVIS-E100

Print article

Channels

Critical Care

view channel
Image: Researchers have developed a novel risk score for cardiovascular complications after bone marrow transplant (Photo courtesy of 123RF)

Novel Tool Predicts Cardiovascular Risks after Bone Marrow Transplantation

Every year, thousands of people undergo bone marrow transplants to potentially cure serious diseases like leukemia, lymphoma, and immune deficiency disorders. While these transplants can be lifesaving,... Read more

Patient Care

view channel
Image: The newly-launched solution can transform operating room scheduling and boost utilization rates (Photo courtesy of Fujitsu)

Surgical Capacity Optimization Solution Helps Hospitals Boost OR Utilization

An innovative solution has the capability to transform surgical capacity utilization by targeting the root cause of surgical block time inefficiencies. Fujitsu Limited’s (Tokyo, Japan) Surgical Capacity... Read more

Health IT

view channel
Image: First ever institution-specific model provides significant performance advantage over current population-derived models (Photo courtesy of Mount Sinai)

Machine Learning Model Improves Mortality Risk Prediction for Cardiac Surgery Patients

Machine learning algorithms have been deployed to create predictive models in various medical fields, with some demonstrating improved outcomes compared to their standard-of-care counterparts.... Read more

Point of Care

view channel
Image: The new eye-safe laser technology can diagnose traumatic brain injury (Photo courtesy of 123RF)

Novel Diagnostic Hand-Held Device Detects Known Biomarkers for Traumatic Brain Injury

The growing need for prompt and efficient diagnosis of traumatic brain injury (TBI), a major cause of mortality globally, has spurred the development of innovative diagnostic technologies.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.